知镜 Cognispect · 医学文献与研究工作台

Prenatal melatonin regulates lung prostanoids expression in newborn sheep exposed to chronic hypoxia.

Figueroa EG, Gonzaléz-Candia A, Villanueva C, Paz AA, Herrera EA.
Biochemical pharmacology · 2026-11-11 · PMID 43014573

文献摘要

Chronic hypoxia during pregnancy disrupts the balance of pulmonary vasoactive agents, altering prostanoid signaling and increasing the contractility of resistance arteries. This leads to elevated pulmonary arterial pressure and vascular resistance, ultimately resulting in pulmonary hypertension of the neonate (PHN). While prenatal melatonin is known to influence vascular tone, its specific impact on the neonatal pulmonary prostanoid system in hypoxic pregnancies remains unclear. This study aimed to determine the effects of third-trimester maternal melatonin administration on the cyclooxygenase and prostanoid pathways, and to evaluate its efficacy in reversing PHN in a high-altitude ovine model. In-vivo and ex-vivo pulmonary vascular function was evaluated in neonatal lambs gestated and born under chronic hypoxia. Furthermore, lung samples from 12-day-old lambs were analyzed using RT-PCR, Western blotting, and immunohistochemistry. The results demonstrate that prenatal melatonin actively modulates the pulmonary vascular function, and the prostanoids system, altering both the transcriptional and translational expression of specific prostanoids, as well as their spatial localization within pulmonary resistance arteries. However, despite this significant molecular and structural modulation, maternal melatonin treatment failed to reverse or clinically improve PHN in the offspring. These findings highlight the complexity of hypoxia-induced vascular remodeling and suggest that melatonin-driven prostanoid modulation alone is insufficient to overcome PHN, although it can improve some pulmonary function in neonates.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。